Clinical Trials Browser

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07169617 2026-03-30

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Phase 2 Not yet recruiting

80 enrolled

Thoracic

Lung Neoplasms

NCT07499986 2026-03-30

Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery

Phase NA Not yet recruiting

70 enrolled

Thoracic

Lung Neoplasms

NCT07149649 2026-03-27

Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 2/3 Not yet recruiting

230 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07438600 2026-03-27

TianjinCIH

Phase 2 Not yet recruiting

38 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07493980 2026-03-27

Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

Phase 2 Not yet recruiting

54 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07495098 2026-03-27

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

Phase 1 Not yet recruiting

12 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07498439 2026-03-27

TILs Therapy for Multiple Primary Early-Stage NSCLC

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Thoracic

Primary Early-stage Non-small Cell Lung Cancer

NCT07498595 2026-03-27

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07492121 2026-03-25

GAPIMET

Phase 2 Not yet recruiting

180 enrolled

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT06943664 2026-03-24

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

27 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07479199 2026-03-24

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

Not yet recruiting

70 enrolled

Thoracic

Neoplasms, Pain, Thoracic Neoplasms

NCT07486648 2026-03-24

Precision

Phase 1/2 Not yet recruiting

53 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07489391 2026-03-24

Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer

Phase NA Not yet recruiting

10 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Motor Activity

NCT07489703 2026-03-24

SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC

Phase 2 Not yet recruiting

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

PASI

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer

Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Cronos

DeLLphi-313

A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer

The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

STAR-01

One-stop

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

ResQ1010-NSCLC: NAI + Chemoimmunotherapy vs Chemoimmunotherapy for First-Line Advanced/Metastatic NSCLC

LUCAS-LATAM

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

EXHALE-CO2

Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial

FIX-SDM LCS

JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study

INTerpath-014

IMPULSION

Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma

Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC

Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC

KontRASt-R

INSTAR

SPECTRAL-1

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)

PREDU

DEFLECT I

ETCABIO

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery

Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

TianjinCIH

Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

TILs Therapy for Multiple Primary Early-Stage NSCLC

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

GAPIMET

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

Precision

Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer

SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC